OnCore LogoStudy Information PortalPowered By Forte Research Systems
SIP Home
Age Group
Location of Cancerbrowse
Drugbrowse
Therapy
Phase
Principal Investigatorbrowse
SearchClear

>Tips for searching:

  • Location of cancer: Use words to describe the location of the cancer, such as "breast", "prostate" or "lung". If you are not sure, click on the magnifying glass to the right to see a complete list of cancer locations.
  • Drug: Click on the magnifying glass and choose the drug name from the list provided. .
  • Therapy: Use the drop-down menu to choose the type of treatment you are looking for, such as "chemotherapy", "radiotherapy", "surgery" or "vaccine".
  • Phase: You can choose from Phases 1-4 by clicking on the drop-down menu-for an explanation of each Phase, please see definitions provided below.
  • Principal Investigator: This is the doctor who is responsible for a particular clinical trial. If you know the name of the doctor, you may type it in this box. If you do not know the name, you may use the magnifying glass to see a list of Principal Investigators who currently have cancer trials at Cedars-Sinai.

**Note: Be sure to click on "search" after entering information into any of the above fields**

Trial Phases (Modified from the National Institute of Health):

  • Phase I trials: Researchers test an experimental drug or treatment in a small group of people (20-80), to evaluate its safety and identify side effects. Often these trials are not disease specific and may include more than one type of cancer.
  • Phase II trials: The experimental drug or treatment is administered to a larger group of people (100-300) to determine its effectiveness and to further evaluate its safety.
  • Phase III trials: The experimental drug or treatment is administered to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it with standard or equivalent treatments, and collect information that will allow the experimental drug or treatment to be used safely.
  • Phase IV trials: After a drug is approved by the FDA and made available to the public, researchers track its safety, seeking more information about a drug or treatment's risks, benefits and optimal use.

For more information about cancer clinical trials, please contact our Clinical Trial Recruitment Navigator by phone at 310-423-2133 or by email at Cancer.Trial.Info@cshs.org